References
- Rodeghiero, F., R. Stasi, T. Gernsheimer, et al. 2009. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 113: 2386–2393
- McKenzie, C. G., L. Guo, J. Freedman, and J. W. Semple. 2013. Cellular immune dysfunction in immune thrombocytopenia (ITP). Br. J. Haematol. 163: 10–23
- Liu, X. G., and M. Hou. 2013. Immune thrombocytopenia and B-cell-activating factor/a proliferation-inducing ligand. Semin. Hematol. 50(Suppl 1): S89–S99
- Basciano, P. A., J. Bussel, Z. Hafeez, et al. 2013. The beta 1 tubulin R307H single nucleotide polymorphism is associated with treatment failures in immune thrombocytopenia (ITP). Br. J. Haematol. 160: 237–243
- Ge, J., H. Li, D. Gu, et al. 2013. PTPN22 -1123G > C polymorphism is associated with susceptibility to primary immune thrombocytopenia in Chinese population. Platelets. 24: 448–453
- Pesmatzoglou, M., M. Lourou, G. N. Goulielmos, and E. Stiakaki. 2012. DNA methyltransferase 3B gene promoter and interleukin-1 receptor antagonist polymorphisms in childhood immune thrombocytopenia. Clin. Dev. Immunol. 2012: 352059
- Sarpatwari, A., J. B. Bussel, M. Ahmed, et al. 2011. Single nucleotide polymorphism (SNP) analysis demonstrates a significant association of tumour necrosis factor-alpha (TNFA) with primary immune thrombocytopenia among Caucasian adults. Hematology. 16: 243–248
- Zhou, B., S. Wang, C. Mayr, et al. 2007. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc. Natl. Acad. Sci. USA. 104: 7080–7085
- Li, Q. J., J. Chau, P. J. Ebert, et al. 2007. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell. 129: 147–161
- Li, J., Y. Wan, Q. Guo, et al. 2010. Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis. Arthritis. Res. Ther. 12: R81
- Wang, G., L. S. Tam, E. K. Li, et al. 2010. Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus. J. Rheumatol. 37: 2516–2522
- Jernås, M., I. Nookaew, H. Wadenvik, and B. Olsson. 2013. MicroRNA regulate immunological pathways in T-cells in immune thrombocytopenia (ITP). Blood. 121: 2095–2098
- Li, H., H. Zhao, F. Xue, et al. 2013. Reduced expression of MIR409-3p in primary immune thrombocytopenia. Br. J. Haematol. 161: 128–135
- Loktionov, A. 2004. Common gene polymorphisms, cancer progression and prognosis. Cancer Lett. 208: 1–33
- Löfgren, S. E., J. Frostegård, L. Truedsson, et al. 2012. Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene. Genes Immun. 13: 268–274
- Zhang, J., J. Zhang, B. Yang, et al. 2011. Association of pre-microRNAs genetic variants with susceptibility in systemic lupus erythematosus. Mol. Biol. Rep. 38: 1463–1468
- Yang, B., J. L. Zhang, Y. Y. Shi, et al. 2011. Association study of single nucleotide polymorphisms in pre-miRNA and rheumatoid arthritis in a Han Chinese population. Mol. Biol. Rep. 38: 4913–4919
- Sakoguchi, A., M. Jinnin, T. Makino, et al. 2013. The miR-146a rs2910164 C/G polymorphism is associated with telangiectasia in systemic sclerosis. Clin. Exp. Dermatol. 38: 99–100
- Fenoglio, C., C. Cantoni, M. De Riz, et al. 2011. Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis. Neurosci. Lett. 504: 9–12